July 2026
The viral vectors and plasmid DNA manufacturing market size is expected to hit USD 29.82 billion by 2035 from USD 7.26 billion in 2025 with a CAGR of 15.17%.
June 2026
The US viral vectors and plasmid DNA manufacturing market size is valued at USD 3.30 billion in 2025 and is predicted to hit USD 11.69 billion by 2035, with a CAGR of 15.20%.
August 2026
The plasmid DNA manufacturing market size was estimated at USD 2.64 billion in 2025 and is expected to hit around USD 12.45 billion by 2035, growing at a CAGR of 16.78%.
May 2026
The U.S. plasmid DNA manufacturing market size was exhibited at USD 810 million in 2025 and is projected to hit USD 4,003 million by 2035, at a CAGR of 18.41%.
September 2026
The viral and non-viral vectors market was valued at USD 9.40 billion in 2025, with leading companies including Thermo Fisher Scientific Inc., Lonza Group AG, Catalent, Inc., WuXi AppTec, Oxford Biomedica plc.
September 2026
The antiviral and antimicrobial technology market is growing with demand for advanced coatings, textiles, and surfaces that prevent infection and contamination.
September 2026
The DNA-based non-viral technologies market was valued at USD 5.60 billion in 2025, with leading companies including Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Rad Laboratories, Inc., Promega Corporation, Qiagen N.V.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
June 2025
The global viral vectors for non human primates market size is estimated to hit around USD 397.87 million by 2034 from USD 145.8 million in 2024, at a CAGR of 10.56%.
September 2026
The bacterial and viral specimen collection market reached USD 59.95 billion in 2026, featuring leading while major growth segments span Puritan Medical Products companies such as Longhorn Vaccines and Diagnostics, LLC.
September 2026
The healthcare contract development and manufacturing organization market size reached USD 291.03 billion in 2026, with leading healthcare contract development and manufacturing organization market companies including onza Group Ltd., Covance Inc., Flex.
August 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 950.00 million in 2025, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
August 2026
By Payal Rabde - Aug 2026 - the global fill finish manufacturing market reached USD 20.00 billion in 2025 and is expected to expand at a CAGR of 9.10% until 2035.
August 2026
The electronic contract manufacturing and design services market size is estimated to hit around USD 1,544.97 billion by 2034 from USD 611.03 billion in 2024 with a CAGR of 9.72%.
August 2026
The global aluminum market size was USD 203.02 billion in 2026 and is projected to reach USD 347.29 billion by 2035 at a 6.16% CAGR, driven by rising demand from automotive, construction, packaging, and renewable energy industries.
June 2026
The global dental implants and prosthetics contract manufacturing market size is estimated to hit around USD 3.41 billion by 2035 increasing from USD 1.55 billion in 2025, with a CAGR of 8.20%.
March 2026
The pharmaceutical contract manufacturing and research services market size is estimated to hit around USD 525.32 billion by 2035, increasing from USD 264.23 billion in 2025, with a CAGR of 7.11%.
February 2026
The global mRNA synthesis and manufacturing market size is estimated to hit around USD 5.64 billion by 2035 increasing from USD 3.19 billion in 2025, with a CAGR of 5.85%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
February 2025
The global contract development manufacturing organization outsourcing market size is projected to hit around USD 824.16 billion by 2034 increasing from USD 171.46 billion in 2024, with a CAGR of 17.00%.
January 2025
The augmented reality (AR) and virtual reality (VR) in manufacturing market size is projected to hit around USD 100.01 billion by 2034 from USD 12.74 billion in 2024 with a CAGR of 22.88%.
September 2026
The metal additive manufacturing market size reached USD 7.59 billion in 2026, with leading metal additive manufacturing market companies including EOS GmbH, BeAM Machines, Wuhan Huake 3D.
September 2026
The generative AI in manufacturing market size reached USD 889.32 million in 2026, with leading generative AI in manufacturing market companies including SAP SE, IBM, Microsoft Corporation.
September 2026
The protein characterization and identification market was worth USD 5.32 billion in 2026, with key protein characterization and identification market players including Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The global clinical trial materials manufacturing market is driven by rising global trials, need for temperature-sensitive logistics, and quality manufacturing.
September 2026
The manufacturing operations management software market reached USD 15.60 billion in 2025, featuring leading manufacturing operations management software market companies such as Siemens, Rockwell Automation, Schneider Electric, GE Digital.
August 2026
The metal and ceramic injection molding market size reached USD 5.03 billion in 2026, with leading metal and ceramic injection molding market companies including Advanced Materials Technologies Pte. Ltd.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
August 2026
Healthcare payment integrity is shifting from a predominantly retrospective recovery function toward earlier and more continuous payment-accuracy management. Payers are increasingly using claims editing, coding validation, clinical review, provider analytics, fraud detection, and AI-assisted screening to identify payment issues before or closer to the point of payment. The global healthcare payment integrity market was valued at USD 16.05 billion in 2025 and is projected to reach USD 60.61 billion by 2035 at a CAGR of 14.21%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com